17
Participants
Start Date
December 31, 2004
Primary Completion Date
January 31, 2008
Study Completion Date
January 31, 2008
Levetiracetam
The initial levetiracetam dose will be 250 mg/day, which will be increased to 250 mg BID after 1 week. The dose will then be increased by 500 mg/day each week (given in BID dosing) to a maximum of 3,000 mg/day. The dose will be raised more slowly or the maximum dose will not be reached if response occurs at a lower dose or side effects are problematic. Subjects who are unable to tolerate at least 500 mg a day of levetiracetam will be withdrawn from the study.
Rhode Island Hospital Body Dysmorphic Disorder Program, Providence
Lead Sponsor
Collaborators (1)
UCB Pharma
INDUSTRY
Butler Hospital
OTHER